TSLP and acute lymphoblastic leukemia: Specifically, high-dose TSLP (10 ng/mL) supports the survival of normal B-cell precursors, whereas higher doses of TSLP (greater than 200 pg/mL) can induce apoptosis in CRLF2 B-ALL cells [104].